Similar Articles

Home | Newsletter | My Articles | My Account | Help

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool May 2, 2007 Mike Havrilla	An Eye-Opening Potential Acquisition The Biotech firm Inspire should consider buying drug-development partner InSite Vision.
The Motley Fool May 14, 2007 Mike Havrilla	Investors Tire of Inspire Pharmaceuticals Shares are down about 10% recently, despite approval for AzaSite.
The Motley Fool April 27, 2011 Frank Vinluan	Inspire's Pink Eye Drug AzaSite Draws Generic Challenge This sought-after drug could soon be facing generic competition.
The Motley Fool May 4, 2007 Mike Havrilla	On Deck in Biotech Investors can keep an eye on possible catalysts for these stocks in the next week: YM BioSciences... DOR BioPharma... IDM Pharma's... etc.